- Supported exchanges /
- NASDAQ /
- FBLG.NASDAQ
FibroBiologics, Inc. Common Stock (FBLG NASDAQ) stock market data APIs
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
FibroBiologics, Inc. Common Stock Financial Data Overview
| 2.88 | |
| 3.28 | |
| - | |
| 3.34 | |
| 2.8201 | |
| 1.078-55 | |
| 115 M | |
| 35 259 K | |
| 0 | |
| -0.02 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
FibroBiologics, Inc. Common Stock Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -11 089 000
- Earnings Per Share -0.59
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get FibroBiologics, Inc. Common Stock Earnings via APIs
- Latest Release 2024-08-07
- EPS/Forecast -0.09
Get FibroBiologics, Inc. Common Stock End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
